Targeting VMPFC‐amygdala circuit with TMS in substance use disorder: A mechanistic framework
Addiction Biology · 2025-01 · 30 (1)
DOI: 10.1111/adb.70011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction Biology, online erschienen am 09.01.2025. Verfasst von Ghazaleh Soleimani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Amygdala, Prefrontal Cortex, Magnetic Resonance Imaging. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Minnesota's MnDRIVE (Minnesota's Discovery, Research and Innovation Economy), University of Minnesota's Medical Discovery Team on Addiction (MDTA).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
The ventromedial prefrontal cortex (VMPFC), located along the medial aspect of the frontal area, plays a critical role in regulating arousal/emotions. Its intricate connections with subcortical structures, including the striatum and amygdala, highlight the VMPFC's importance in the neurocircuitry of addiction. Due to these features, the VMPFC is considered a promising target for transcranial magnetic stimulation (TMS) in substance use disorders (SUD). By the end of 2023, all 21 studies targeting VMPFC for SUD used anatomical landmarks (e.g., Fp1/Fp2 in the EEG system) to define coil location with a fixed orientation. Nevertheless, one‐size‐fits‐all TMS over VMPFC has yielded variable outcomes. Here, we suggested a pipeline based on a tailored TMS targeting framework aimed at optimally modulating the VMPFC‐amygdala circuit on an individual basis. We collected MRI data from 60 participants with methamphetamine use disorders (MUDs). We examined the variability in TMS target location based on task‐based functional connectivity between VMPFC and amygdala using psychophysiological interaction (PPI) analysis. Electric fields (EF) were calculated for fixed vs. optimized location (Fp1/Fp2 vs. individualized maximal PPI), orientation (AF7/AF8 vs. optimized algorithm) and intensity (constant vs. adjusted) to maximize target engagement. In our pipeline, the left medial amygdala, identified as the brain region with the highest (0.31 ± 0.29) fMRI drug cue reactivity, was selected as the subcortical seed region. The voxel with the most positive amygdala‐VMPFC PPI connectivity in each participant was considered the individualized TMS target (MNI‐coordinates: [12.6, 64.23, −0.8] ± [13.64, 3.50, 11.01]). This individualized VMPFC‐amygdala connectivity significantly correlated with VAS craving after cue exposure (R = 0.27, p = 0.03). Coil orientation was optimized to increase EF strength over the targeted circuit (0.99 ± 0.21 V/m vs. the fixed approach: Fp1: 0.56 ± 0.22 and Fp2: 0.78 ± 0.25 V/m) and TMS intensity was harmonized across the population. This study highlights the potential of an individualized VMPFC targeting framework to enhance treatment outcomes for addiction, specifically modulating the personalized VMPFC‐amygdala circuit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA.
- Laureate Institute for Brain Research (LIBR), Oklahoma, USA.
ORCID-Profile: Ghazaleh Soleimani
Förderung
- University of Minnesota's MnDRIVE (Minnesota's Discovery, Research and Innovation Economy)
- University of Minnesota's Medical Discovery Team on Addiction (MDTA)
Zitieren
APA
Soleimani, G., Conelea, C. A., Kuplicki, R., Opitz, A., Lim, K. O., Paulus, M. P., & Ekhtiari, H. (2025). Targeting VMPFC‐amygdala circuit with TMS in substance use disorder: A mechanistic framework. Addiction Biology, 30(1). https://doi.org/10.1111/adb.70011
Vancouver
Soleimani G, Conelea CA, Kuplicki R, Opitz A, Lim KO, Paulus MP, et al. Targeting VMPFC‐amygdala circuit with TMS in substance use disorder: A mechanistic framework. Addiction Biology. 2025;30(1). doi:10.1111/adb.70011
BibTeX
@article{Soleimani2025,
author = {Soleimani, Ghazaleh and Conelea, Christine A and Kuplicki, Rayus and Opitz, Alexander and Lim, Kelvin O and Paulus, Martin P and Ekhtiari, Hamed},
title = {Targeting VMPFC‐amygdala circuit with TMS in substance use disorder: A mechanistic framework},
journal = {Addiction Biology},
year = {2025},
volume = {30},
number = {1},
doi = {10.1111/adb.70011}
}
EUVIMED